Aerovance
Aerovance is a biotech company focused on developing and commercializing medicines for respiratory and allergic diseases.
Business Model:
Revenue: $10M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Aerovance Information
Geographic Data
Address:
City: Berkeley
State: California
Zip:
Country: United States
Financial Info
Stage:
series unknown
Raised Last:
$500k
Raised Total:$153M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Aerovance is a privately held biopharmaceutical company exclusively focused on developing and commercializing breakthrough medicines for respiratory and allergic diseases. The company maintains a solid intellectual property position with its strong portfolio of novel therapeutic candidates now in clinical development and several pre-clinical programs. The two lead products are human recombinant proteins: Aerovantâ„¢, an IL-4 and -13 receptor antagonist which is in Phase IIa studies for asthma and Aerodermâ„¢, a PEGylated IL-4 and IL-13 receptor antagonist in pre-clinical studies for eczema.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2004 | Series B | 4 | $32M |
Apax Partners Burrill &a; Company Lehman Brothers NGN Capital Apax Partners Burrill &a; Company Lehman Brothers NGN Capital |
3/2008 | Debt Financing | 2 | $20M |
Comerica Incorporated Silicon Valley Bank Comerica Incorporated Silicon Valley Bank |
4/2009 | Venture Round | 8 | $38M |
Lehman Brothers Alta Partners Apax Partners BB Biotech Ventures Burrill &a; Company Clarus Ventures NGN Capital ProQuest Investments Alta Partners Apax Partners BB Biotech Ventures Burrill &a; Company Clarus Ventures Lehman Brothers NGN Capital ProQuest Investments |
3/2007 | Series C | 6 | $60M |
Alta Partners Apax Partners Burrill &a; Company Clarus Ventures Lehman Brothers NGN Capital Alta Partners Apax Partners Burrill &a; Company Clarus Ventures Lehman Brothers NGN Capital |
3/2011 | Venture Round | $500k | 9/2010 | Debt Financing | $2M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
